z-logo
open-access-imgOpen Access
Prediction of cancer survival for cohorts of patients most recently diagnosed using multi-model inference
Author(s) -
Camille Maringe,
Aurélien Belot,
Bernard Rachet
Publication year - 2020
Publication title -
statistical methods in medical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.952
H-Index - 85
eISSN - 1477-0334
pISSN - 0962-2802
DOI - 10.1177/0962280220934501
Subject(s) - akaike information criterion , model selection , statistics , inference , relative survival , survival analysis , population , bayesian inference , econometrics , covariate , proportional hazards model , selection (genetic algorithm) , cancer , bayesian probability , medicine , cancer registry , mathematics , computer science , artificial intelligence , environmental health
Despite a large choice of models, functional forms and types of effects, the selection of excess hazard models for prediction of population cancer survival is not widespread in the literature. We propose multi-model inference based on excess hazard model(s) selected using Akaike information criteria or Bayesian information criteria for prediction and projection of cancer survival. We evaluate the properties of this approach using empirical data of patients diagnosed with breast, colon or lung cancer in 1990-2011. We artificially censor the data on 31 December 2010 and predict five-year survival for the 2010 and 2011 cohorts. We compare these predictions to the observed five-year cohort estimates of cancer survival and contrast them to predictions from an a priori selected simple model, and from the period approach. We illustrate the approach by replicating it for cohorts of patients for which stage at diagnosis and other important prognosis factors are available. We find that model-averaged predictions and projections of survival have close to minimal differences with the Pohar-Perme estimation of survival in many instances, particularly in subgroups of the population. Advantages of information-criterion based model selection include (i) transparent model-building strategy, (ii) accounting for model selection uncertainty, (iii) no a priori assumption for effects, and (iv) projections for patients outside of the sample.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom